113 related articles for article (PubMed ID: 12601490)
1. Steady-state sVCAM-1 serum levels in adults with sickle cell disease.
Schnog JB; Rojer RA; Mac Gillavry MR; Ten Cate H; Brandjes DPM; Duits AJ
Ann Hematol; 2003 Feb; 82(2):109-113. PubMed ID: 12601490
[TBL] [Abstract][Full Text] [Related]
2. Erythropoiesis and serum sVCAM-1 levels in adults with sickle cell disease.
Duits AJ; Rojer RA; van Endt T; MacGillavry MR; ten Cate H; Brandjes DP; Schnog JB
Ann Hematol; 2003 Mar; 82(3):171-4. PubMed ID: 12634950
[TBL] [Abstract][Full Text] [Related]
3. Plasma zinc levels inversely correlate with vascular cell adhesion molecule-1 concentration in children with sickle cell disease.
Kuvibidila SR; Sandoval M; Lao J; Velez M; Yu L; Ode D; Gardner R; Lane G; Warrier RP
J Natl Med Assoc; 2006 Aug; 98(8):1263-72. PubMed ID: 16916123
[TBL] [Abstract][Full Text] [Related]
4. Increased levels of soluble ICAM-1 in the plasma of sickle cell patients are reversed by hydroxyurea.
Conran N; Fattori A; Saad ST; Costa FF
Am J Hematol; 2004 Aug; 76(4):343-7. PubMed ID: 15282666
[TBL] [Abstract][Full Text] [Related]
5. Protein C and S and inflammation in sickle cell disease.
Schnog JB; Mac Gillavry MR; van Zanten AP; Meijers JC; Rojer RA; Duits AJ; ten Cate H; Brandjes DP
Am J Hematol; 2004 May; 76(1):26-32. PubMed ID: 15114593
[TBL] [Abstract][Full Text] [Related]
6. Elevated plasma sVCAM-1 levels in children with sickle cell disease: impact of chronic transfusion therapy.
Sakhalkar VS; Rao SP; Weedon J; Miller ST
Am J Hematol; 2004 May; 76(1):57-60. PubMed ID: 15114598
[TBL] [Abstract][Full Text] [Related]
7. Cytokine profile of sickle cell disease in Oman.
Pathare A; Al Kindi S; Alnaqdy AA; Daar S; Knox-Macaulay H; Dennison D
Am J Hematol; 2004 Dec; 77(4):323-8. PubMed ID: 15551290
[TBL] [Abstract][Full Text] [Related]
8. Enhanced levels of soluble VCAM-1 in sickle cell patients and their specific increment during vasoocclusive crisis.
Duits AJ; Pieters RC; Saleh AW; van Rosmalen E; Katerberg H; Berend K; Rojer RA
Clin Immunol Immunopathol; 1996 Oct; 81(1):96-8. PubMed ID: 8808648
[TBL] [Abstract][Full Text] [Related]
9. Levels of endothelial, neutrophil and platelet-specific factors in sickle cell anemia patients during hydroxyurea therapy.
Saleh AW; Hillen HF; Duits AJ
Acta Haematol; 1999; 102(1):31-7. PubMed ID: 10473885
[TBL] [Abstract][Full Text] [Related]
10. Association of homocysteine and inflammatory-related molecules in sickle cell anemia.
Vilas-Boas W; Veloso Cerqueira BA; Figueiredo CV; Santiago RP; da Guarda CC; Pitanga TN; Santana SS; Dias Zanette AM; Goncalves Mde S
Hematology; 2016 Mar; 21(2):126-31. PubMed ID: 26334689
[TBL] [Abstract][Full Text] [Related]
11. Arginase levels and their association with Th17-related cytokines, soluble adhesion molecules (sICAM-1 and sVCAM-1) and hemolysis markers among steady-state sickle cell anemia patients.
Vilas-Boas W; Cerqueira BA; Zanette AM; Reis MG; Barral-Netto M; Goncalves MS
Ann Hematol; 2010 Sep; 89(9):877-82. PubMed ID: 20405289
[TBL] [Abstract][Full Text] [Related]
12. Childhood sickle cell crises: clinical severity, inflammatory markers and the role of interleukin-8.
Etienne-Julan M; Belloy MS; Decastel M; Dougaparsad S; Ravion S; Hardy-Dessources MD
Haematologica; 2004 Jul; 89(7):863-4. PubMed ID: 15257940
[TBL] [Abstract][Full Text] [Related]
13. Markers of endothelial dysfunction and leucocyte activation in Saudi and non-Saudi haplotypes of sickle cell disease.
Al Najjar S; Adam S; Ahmed N; Qari M
Ann Hematol; 2017 Jan; 96(1):141-146. PubMed ID: 27686084
[TBL] [Abstract][Full Text] [Related]
14. Effect of red cell exchange transfusion on plasma levels of inflammatory mediators in sickle cell patients with acute chest syndrome.
Liem RI; O'Gorman MR; Brown DL
Am J Hematol; 2004 May; 76(1):19-25. PubMed ID: 15114592
[TBL] [Abstract][Full Text] [Related]
15. Clinical relevance of vascular endothelial growth factor levels in sickle cell disease.
Gürkan E; Tanriverdi K; Başlamişli F
Ann Hematol; 2005 Feb; 84(2):71-5. PubMed ID: 15322765
[TBL] [Abstract][Full Text] [Related]
16. Serum levels of soluble vascular cell adhesion molecules may correlate with the severity of dengue virus-1 infection in adults.
Liao B; Tang Y; Hu F; Zhou W; Yao X; Hong W; Wang J; Zhang X; Tang X; Zhang F
Emerg Microbes Infect; 2015 Apr; 4(4):e24. PubMed ID: 26421267
[TBL] [Abstract][Full Text] [Related]
17. Coagulation activation and inflammation in sickle cell disease-associated pulmonary hypertension.
Ataga KI; Moore CG; Hillery CA; Jones S; Whinna HC; Strayhorn D; Sohier C; Hinderliter A; Parise LV; Orringer EP
Haematologica; 2008 Jan; 93(1):20-6. PubMed ID: 18166781
[TBL] [Abstract][Full Text] [Related]
18. Inhaled steroids reduce pain and sVCAM levels in individuals with sickle cell disease: A triple-blind, randomized trial.
Glassberg J; Minnitti C; Cromwell C; Cytryn L; Kraus T; Skloot GS; Connor JT; Rahman AH; Meurer WJ
Am J Hematol; 2017 Jul; 92(7):622-631. PubMed ID: 28370266
[TBL] [Abstract][Full Text] [Related]
19. Plasma levels of TNF-alpha in sickle cell patients receiving hydroxyurea.
Tavakkoli F; Nahavandi M; Wyche MQ; Perlin E
Hematology; 2004 Feb; 9(1):61-4. PubMed ID: 14965870
[TBL] [Abstract][Full Text] [Related]
20. Plasma levels of asymmetric dimethylarginine (ADMA), an endogenous nitric oxide synthase inhibitor, are elevated in sickle cell disease.
Schnog JB; Teerlink T; van der Dijs FP; Duits AJ; Muskiet FA;
Ann Hematol; 2005 May; 84(5):282-6. PubMed ID: 15599544
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
